Thorac Cardiovasc Surg
DOI: 10.1055/a-2382-8087
Original Thoracic

Evaluation of Risk Factors for Early Insufficiency after Bronchial Sleeve Resections

Evgeny Levchenko
1   Department of Thoracic Oncology, N. N. Petrov National Medical Research Center of Oncology, Sankt-Peterburg, Russian Federation
,
1   Department of Thoracic Oncology, N. N. Petrov National Medical Research Center of Oncology, Sankt-Peterburg, Russian Federation
,
Nikita Levchenko
1   Department of Thoracic Oncology, N. N. Petrov National Medical Research Center of Oncology, Sankt-Peterburg, Russian Federation
,
Alexander Mikhnin
1   Department of Thoracic Oncology, N. N. Petrov National Medical Research Center of Oncology, Sankt-Peterburg, Russian Federation
,
Oleg Mamontov
1   Department of Thoracic Oncology, N. N. Petrov National Medical Research Center of Oncology, Sankt-Peterburg, Russian Federation
,
Stepan Ergnyan
1   Department of Thoracic Oncology, N. N. Petrov National Medical Research Center of Oncology, Sankt-Peterburg, Russian Federation
› Author Affiliations

Abstract

Background Bronchoplastic resections are now widely used as a surgical treatment for resectable central lung cancer. However, bronchial dehiscence is one of the most life-threatening complications, making it important to identify its risk factors to separate patients who require more attention during the postoperative period.

Methods The data of 285 patients who underwent bronchoplasty from 2006 to 2021 were retrospectively reviewed. We collected demographic characteristics, history of neoadjuvant therapy, preoperative assessment, perioperative outcomes, and postoperative complications to investigate different variables as risk factors for bronchial dehiscence by univariate and multivariate analyses.

Results Bronchial dehiscence was diagnosed in 12 patients (4.2%) with a mean presentation on postoperative day 10 (range: 1–24 days). By multivariate analysis, current smoking (odds ratio [OR]: 4.8, 95% confidence interval [CI]: 1.1–20.1, p = 0.032), chronic obstructive pulmonary disease (COPD; OR: 6.5, 95% CI: 1.2–33.8, p = 0.027), bronchoplastic right lower lobectomy (OR: 12.9, 95% CI: 2.4–69.7, p = 0.003), and upper sleeve bilobectomy with segmentectomy S6 by performing an anastomosis between right main bronchus (RMB) and bronchus of basal pyramid (BP) (OR: 30.4, 95% CI: 3.4–268.1, p = 0.002) were confirmed as relevant risk factors for developing bronchial dehiscence.

Conclusion Current smoking, COPD, bronchoplastic right lower lobe, and upper l with segmentectomy S6 by performing an anastomosis between RMB and bronchus of BP were identified with the occurrence of bronchial dehiscence after sleeve resection.



Publication History

Received: 13 February 2024

Accepted: 06 August 2024

Accepted Manuscript online:
08 August 2024

Article published online:
29 August 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Li Z, Chen W, Xia M. et al. Sleeve lobectomy compared with pneumonectomy for operable centrally located non-small cell lung cancer: a meta-analysis. Transl Lung Cancer Res 2019; 8 (06) 775-786
  • 2 Chen J, Soultanis KM, Sun F. et al. Outcomes of sleeve lobectomy versus pneumonectomy: a propensity score-matched study. J Thorac Cardiovasc Surg 2021; 162 (06) 1619-1628.e4
  • 3 Lopez-Pastorini A, Eckermann C, Koryllos A. et al. Clinical and bronchoscopic aspects of bronchial healing after sleeve resection for lung cancer: a multivariate analysis on 541 cases. J Thorac Dis 2022; 14 (04) 927-938
  • 4 Peng Z, Mei J, Liu C. et al. Risk factors and outcomes of bronchopleural fistula after bronchoplasty in patients with non-small cell lung cancer: a retrospective multivariate analysis. Transl Lung Cancer Res 2022; 11 (05) 744-756
  • 5 Maurizi G, D'Andrilli A, Venuta F, Rendina EA. Reconstruction of the bronchus and pulmonary artery. J Thorac Dis 2016; 8 (Suppl. 02) S168-S180
  • 6 Rendina EA, Venuta F, Ricci P. et al. Protection and revascularization of bronchial anastomoses by the intercostal pedicle flap. J Thorac Cardiovasc Surg 1994; 107 (05) 1251-1254
  • 7 Venuta F, Diso D, Anile M, Rendina EA. Techniques of protection and revascularization of the bronchial anastomosis. J Thorac Dis 2016; 8 (Suppl. 02) S181-S185
  • 8 Palade E, Holdt H, Passlick B. Bronchus anastomosis after sleeve resection for lung cancer: does the suture technique have an impact on postoperative complication rate?. Interact Cardiovasc Thorac Surg 2015; 20 (06) 798-804
  • 9 Algar FJ, Alvarez A, Aranda JL, Salvatierra A, Baamonde C, López-Pujol FJ. Prediction of early bronchopleural fistula after pneumonectomy: a multivariate analysis. Ann Thorac Surg 2001; 72 (05) 1662-1667
  • 10 Thomas PA, Falcoz PE, Bernard A. et al; EPITHOR group. Bilobectomy for lung cancer: contemporary national early morbidity and mortality outcomes. Eur J Cardiothorac Surg 2016; 49 (02) e38-e43 , discussion e43
  • 11 Tokunaga Y, Kita Y, Okamoto T. Analysis of risk factors for bronchopleural fistula after surgical treatment of lung cancer. Ann Thorac Cardiovasc Surg 2020; 26 (06) 311-319
  • 12 Koryllos A, Lopez-Pastorini A, Zalepugas D, Ludwig C, Hammer-Helmig M, Stoelben E. Bronchus anastomosis healing depending on type of neoadjuvant therapy. Ann Thorac Surg 2020; 109 (03) 879-886
  • 13 Chriqui LE, Forster C, Lovis A. et al. Is sleeve lobectomy safe after induction therapy?-a systematic review and meta-analysis. J Thorac Dis 2021; 13 (10) 5887-5898
  • 14 Storelli E, Tutic M, Kestenholz P. et al. Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapy. Eur J Cardiothorac Surg 2012; 42 (01) 77-81
  • 15 Ludwig C. Chirurgische Versorgung tracheo-/bronchopleuraler Fisteln nach bronchoplastischer Resektion (Manschetten–/Bifurkationsresektion) [Surgical treatment of tracheopleural and bronchopleural fistulas after bronchoplastic resection (sleeve or bifurcation resection)]. [Article in German] Chirurg 2019; 90 (09) 704-709
  • 16 Ichinose J, Hashimoto K, Matsuura Y, Nakao M, Okumura S, Mun M. Risk factors for bronchopleural fistula after lobectomy for lung cancer. J Thorac Dis 2023; 15 (06) 3330-3338
  • 17 Ye C, Yuan L, Wu K, Shen B, Zhu C. Association between systemic immune-inflammation index and chronic obstructive pulmonary disease: a population-based study. BMC Pulm Med 2023; 23 (01) 295
  • 18 Li SJ, Zhou XD, Huang J, Liu J, Tian L, Che GW. A systematic review and meta-analysis-does chronic obstructive pulmonary disease predispose to bronchopleural fistula formation in patients undergoing lung cancer surgery?. J Thorac Dis 2016; 8 (07) 1625-1638
  • 19 Inui K, Takahashi Y, Hasegawa S. et al. Effect of preoperative irradiation on wound healing after bronchial anastomosis in mongrel dogs. J Thorac Cardiovasc Surg 1993; 106 (06) 1059-1064
  • 20 Campisi A, Ciarrocchi AP, Congiu S. et al. Sleeve lobectomy: to wrap or not to wrap the bronchial anastomosis?. Ann Thorac Surg 2022; 113 (01) 250-255
  • 21 Carbognani P, Corradi A, Bobbio A. et al. Histological and immunohistochemical study of the bronchial stump with flap coverage in an animal model. Eur Surg Res 2003; 35 (01) 54-57
  • 22 Ishihara T, Nemoto E, Kikuchi K, Kato R, Kobayashi K. Does pleural bronchial wrapping improve wound healing in right sleeve lobectomy?. J Thorac Cardiovasc Surg 1985; 89 (05) 665-672
  • 23 Gharagozloo F, Meyer M. Diaphragmatic flap: technique of preparation and indications for use. World J Cardiovasc Surg 2022; 12: 207-218